Nura Bio: Funding, Investors & Team (Oct 2026)
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders. Its research focuses on preserving neuronal integrity by targeting pathways involved in axonal degeneration and neuroimmune regulation. The company is advancing small-molecule programs, including inhibitors of the SARM1 protein, which plays a key role in axon degeneration. Nura Bio operates an integrated drug discovery platform that supports activities from target identification and validation through preclinical development. Its scientific efforts aim to address diseases affecting the peripheral, central, and ocular nervous systems.
Nura Bio has raised $73.8M across 1 funding round on record, the most recent a Series B of $73.8M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nura Bio Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Nura Bio Funding Rounds
Nura Bio Founders and Leadership Team
Contact details for the Nura Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Nura Bio Funding Compared to Other Biotechnology Startups
Nura Bio's latest round of $73.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nura Bio in Biotechnology and South San Francisco
Companies Similar to Nura Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Nura Bio Funding FAQs
What does Nura Bio do?
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders. Its research focuses on preserving neuronal integrity by targeting pathways involved in axonal degeneration and neuroimmune regulation. The company is advancing small-molecule programs, including inhibitors of the SARM1 protein, which plays a key role in axon degeneration. Nura Bio operates an integrated drug discovery platform that supports activities from target identification and validation through preclinical development. Its scientific efforts aim to address diseases affecting the peripheral, central, and ocular nervous systems.
How much funding has Nura Bio raised?
Nura Bio has raised $73.8M across 1 round on record. The most recent is a Series B of $73.8M announced in Jun 2026.
When did Nura Bio last raise funding?
Nura Bio's most recent funding round on record is a Series B of $73.8M, announced in Jun 2026.
Who founded Nura Bio?
FundedIQ lists Shilpa Sambashivan (Founder) at Nura Bio.
Where is Nura Bio headquartered?
Nura Bio is based in South San Francisco, California, United States.
How many employees does Nura Bio have?
Nura Bio is in the 11-50 employee band.
How does Nura Bio's funding compare to other Biotechnology startups?
Nura Bio's latest round of $73.8M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nura Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nura Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.